Symmetry-breaking considerations play an important role in allowing reliable and accurate predictions of complex systems in quantum many-body simulations. The general theory of perturbations in symmetry-breaking phases is nonetheless intrinsically more involved than in the unbroken phase due to non-vanishing anomalous Green's functions or anomalous quasiparticle interactions. In the present paper, we develop a formulation of many-body theory at non-zero temperature which is explicitly covariant with respect to a group containing Bogoliubov transformations. Based on the concept of Nambu tensors, we derive a factorisation of standard Feynman diagrams that is valid for a general Hamiltonian. The resulting factorised amplitudes are indexed over the set of un-oriented Feynman diagrams with fully antisymmetric vertices. We argue that, within this framework, the design of symmetry-breaking many-body approximations is simplified.
Current models of inter-nucleon interactions are built within the frame of Effective Field Theories (EFTs). Contrary to traditional nuclear potentials, EFT interactions require a renormalization of their parameters in order to derive meaningful estimations of observable. In this paper, a renormalization procedure is designed in connection with many-body approximations applicable to large-A systems and formulated within the frame of many-body perturbation theory. The procedure is shown to generate counterterms that are independent of the targeted A-body sector. As an example, the procedure is applied to the random phase approximation. This work constitutes one step towards the design of a practical EFT for many-body systems.PACS. 21.30.-x Nuclear forces -21.60.De Ab initio methods arXiv:1908.07578v1 [nucl-th]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.